1832 Asset Management L.P. reduced its position in shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 45.3% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 442,915 shares of the pharmacy operator’s stock after selling 366,880 shares during the period. 1832 Asset Management L.P.’s holdings in Walgreens Boots Alliance were worth $36,947,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of WBA. Jolley Asset Management LLC boosted its stake in shares of Walgreens Boots Alliance by 104.5% in the second quarter. Jolley Asset Management LLC now owns 1,370 shares of the pharmacy operator’s stock worth $114,000 after buying an additional 700 shares during the last quarter. Westbourne Investment Advisors Inc. bought a new position in shares of Walgreens Boots Alliance during the second quarter worth about $121,000. Cribstone Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the second quarter worth about $149,000. MU Investments Co. Ltd. bought a new position in shares of Walgreens Boots Alliance during the second quarter worth about $150,000. Finally, Signaturefd LLC raised its position in shares of Walgreens Boots Alliance by 2.7% in the second quarter. Signaturefd LLC now owns 1,802 shares of the pharmacy operator’s stock worth $150,000 after buying an additional 48 shares during the period. Hedge funds and other institutional investors own 59.92% of the company’s stock.

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded up 0.22% on Friday, reaching $81.05. 3,802,604 shares of the company’s stock were exchanged. Walgreens Boots Alliance Inc. has a 52 week low of $71.50 and a 52 week high of $87.05. The stock’s 50 day moving average is $80.51 and its 200 day moving average is $80.87. The company has a market cap of $87.80 billion, a price-to-earnings ratio of 21.22 and a beta of 1.19.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, October 20th. The pharmacy operator reported $1.07 EPS for the quarter, topping the Zacks’ consensus estimate of $0.99 by $0.08. Walgreens Boots Alliance had a return on equity of 16.33% and a net margin of 3.56%. The company had revenue of $28.60 billion for the quarter, compared to analysts’ expectations of $29.06 billion. During the same quarter last year, the business earned $0.88 earnings per share. Walgreens Boots Alliance’s revenue was up .4% on a year-over-year basis. On average, equities analysts anticipate that Walgreens Boots Alliance Inc. will post $5.01 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, December 12th. Investors of record on Thursday, November 17th will be given a $0.375 dividend. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date is Tuesday, November 15th. Walgreens Boots Alliance’s payout ratio is currently 39.27%.

A number of equities analysts recently issued reports on WBA shares. Credit Suisse Group AG reaffirmed a “buy” rating and set a $82.51 target price (down previously from $95.00) on shares of Walgreens Boots Alliance in a research report on Monday, July 18th. Deutsche Bank AG reaffirmed a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 18th. Keefe, Bruyette & Woods reaffirmed an “underperform” rating on shares of Walgreens Boots Alliance in a research report on Friday, July 22nd. Leerink Swann reaffirmed an “outperform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, August 30th. Finally, Bank of America Corp. reaffirmed a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research report on Tuesday, August 30th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fourteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $90.30.

In other Walgreens Boots Alliance news, insider Stefano Pessina bought 2,000,000 shares of the firm’s stock in a transaction on Friday, November 4th. The shares were purchased at an average price of $81.41 per share, for a total transaction of $162,820,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Kathleen Wilson-Thompson sold 23,996 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $85.00, for a total value of $2,039,660.00. The disclosure for this sale can be found here. 21.10% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.